治疗肝综合征的特里普林素
1Division of Gastroenterology & Hepatology, Department of Medicine, Toronto General Hospital, University of Toronto, Ontario, Canada.
新的指南更新了肝综合征-急性损伤 (HRS-AKI) 诊断. 一种新的治疗方法特里普林素,在约40%的患者中有效逆转HRS-AKI,改善了生存率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 胃肠病学 胃肠病学
背景情况:
- 最近的更新修订了肝综合征-急性损伤 (HRS-AKI) 的定义和诊断标准.
- 作为一种强有力的血管收缩剂的特利普林素现在是美国HRS-AKI的批准药物治疗方法.
研究的目的:
- 为读者提供有关HRS-AKI.I.最新诊断标准的信息.
- 为 HRS-AKI 治疗中特利普林素的最佳使用提供指导.
主要方法:
- 对最近临床发现和随机对照试验关于特利普林素疗效的审查.
- 分析特里普林素的使用 (大注 vs. 连续输注) 和反应定义.
主要成果:
- 特里普林在约40%的患者中实现了HRS-AKI逆转,持续输液在剂量和副作用方面提供了潜在的好处.
- 此前对特里普林素的反应被定义为血清肌素<1.5 mg/dl,较新的研究表明基线的值<0.3 mg/dl.
- 潜在的副作用包括缺血事件和呼吸衰竭,需要仔细选择和监测患者.
结论:
- 有效使用特里普林需要仔细选择患者和密切监测.
- 用terlipressin成功逆转HRS-AKI与改善患者存活率和减少对脏替代疗法的需求有关.
更多相关视频
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
16:19Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
